Acne Medication Market size to surpass $17.5 Bn by 2032

Acne Medication Market is slated to cross USD 17.5 billion by 2032, according to a new research report by Global Market Insights Inc.
 

The study claims that an increased consciousness regarding facial aesthetics may stimulate product demand. Over the years, people have become increasingly obsessed with having clear and glowing skin as it makes them feel attractive, desired, and confident.
 

These desires, in association with the increasing prevalence of acne issues among adolescents and young adults, especially between 12 and 24 years of age, are likely to bolster the sales of acne medication during the projection period. The noticeable surge in dermatological examinations and acne treatment procedures will accelerate business progress.
 

Positive outcomes in minimizing acne breakouts to boost the demand for topical acne medication

Acne medication market from topical segment is anticipated to witness over 5.5% CAGR from 2023 to 2032. Topical acne formulations contain several over-the-counter medications having chemicals, such as benzoyl peroxide, salicylic acid, adapalene, alpha hydroxy acids, and others, as their active ingredients. Topical antibiotics might reduce the occurrence of clogged pores and help reduce inflammation while controlling the growth of acne-causing bacteria. The lower risk of drug interactions and systemic adverse events involved in these medications will increase the topical market share.
 

Increased affordability to bolster the sales of salicylic acid-based acne medications

Acne medication market from salicylic acid segment is primed to reach over USD 2.9 billion by 2032. Salicylic acid is a beta hydroxy acid that exfoliates the skin, smoothens skin texture, and reduces the occurrence of mild acne, whiteheads, blackheads, and breakouts. The product comes in different formulations, is highly affordable, skin-friendly, and is easily available across all sales channels, creating favorable growth prospects for the acne medication industry.
 

Browse key industry insights spread across 187 pages with 287 market data tables & 20 figures & charts from the report, “Acne Medication Market Analysis By Formulation (Topical, Oral), By Product (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid), By Type (Prescription, OTC), By Acne (Inflammatory Acne, Non-Inflammatory Acne), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, E-commerce), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/acne-medication-market
 

OTC medications to gain traction due to their effectiveness in treating mild to severe acne

Acne medication market from OTC segment garnered over USD 4.5 billion in 2022. The segment revenues are driven by the easy availability of a wide range of over-the-counter or non-prescription acne medications in the market and their high efficacy in treating mild to moderate acne. These medications involve lesser side effects, are relatively more affordable, and feel comfortable on the skin, thus are expected to gain significant traction.
 

Non-inflammatory acne medications to gain popularity due to surging incidences of given condition in adolescents

Acne medication market from the non-inflammatory acne segment value exceeded a valuation of USD 4.2 billion in 2022. Non-inflammatory acne is recognized by skin issues such as blackheads and whiteheads and rarely exhibits any redness, swelling, or inflammation. The increasing prevalence of the given skin condition in young adults and adolescents, coupled with their desire to have flawless skin, will foster product adoption and will prove conducive to market development.
 

E-commerce segment revenues to surge due to expanding network of online pharmacies

E-commerce segment is poised to depict more than 7% CAGR and record an estimated valuation of over USD 4.4 billion by 2032. The segmental gains can be credited to the proliferation of several online pharmacies offering a wide range of pharmaceuticals at competitive prices. E-commerce platforms ensure contactless doorstep product delivery services that gained tremendous popularity during the pandemic and may stimulate the industry revenue.
 

Noticeable rise in aesthetic expenditure to drive product demand across North America

North America acne medication market amassed more than 53% revenue share in 2022. The regional industry is backed by the surging incidences of people suffering from severe acne problems and the strong presence of leading market players in the region. Besides, people in developed economies such as the U.S. and Canada have been making significant expenditure to improve their facial aesthetics. The considerable rise in acne treatment procedures and dermatological examinations will fuel the regional landscape.
 

Increasing R&D practices to stimulate competitive landscape

Notable players in the acne medication industry are Allergan (AbbVie), Galderma S.A., Reckitt Benckiser Group plc, Bausch Health, Stiefel Laboratories (GlaxoSmithKline plc), Bayer AG, Almirall SA, Paratek Pharmaceuticals, Teva Pharmaceutical Industries, Akorn Operating, LLC, Sun Pharmaceuticals, Pfizer, Inc., Viatris, Mayne Pharmaceuticals, and Procter & Gamble.